Clinical Trial Update: Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether aggressive glucose lowering with pioglitazone reduces in-stent restenosis in patients with type 2 diabetes unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (pioglitazone) (pioglitazone)

Snippet

Sponsor: Queen Elizabeth II Health Sciences Centre | Conditions: Coronary Artery Disease, Angina Pectoris | Phase 4 | Status: COMPLETED